Arthritis Research & Therapy

official impact factor 4.36

Open Access

Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis

S Guiducci, A Del Rosso, M Cinelli, F Perfetto, R Livi, A Rossi, A Gabrielli, R Giacomelli, N Iori, G Fibbi, M Del Rosso and M Matucci Cerinic*

Arthritis Research & Therapy 2005, 7:R1244-R1253 doi:10.1186/ar1815

Accesses  

  • Last 30 days: 22 accesses
  • Last 365 days: 411 accesses
  • All time: 3124 accesses